Skip to content

Micro-osteoperforations and Tooth Movement

Micro-osteoperforations and Tooth Movement: A Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02473471
Enrollment
35
Registered
2015-06-16
Start date
2015-04-30
Completion date
2016-11-30
Last updated
2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malocclusion

Keywords

Micro-Osteoperforation (MOPs), regional acceleratory phenomenon (RAP), Malocculsion

Brief summary

The purpose of this study is determine the effect the Microosteoperforation (MOPs) using the miniscrew on the rate tooth movement. Moreover, measurement of the level of the pain and pain's interference, the level of satisfaction and comfort using this protocol. Finally root resorption associate with this technique will be evaluated.

Detailed description

This study will be randomized, split mouth design controlled trial with a 1:1 allocation ratio. One resident (A.A), calibrated by the main supervisor (S.M), will be reliable for recruiting the subjects, undertaking the orthodontic treatment under the supervision. The eligibility of the cases will be reevaluated by main supervisor (E.M) before the start of treatment. Split mouth design will be utilized with MOPs that will be randomly assigned to the patients' left or right sides to eliminate the possibility of uneven occlusal forces because of habitual occlusion predominantly on 1 side and also the eliminate the biological variability between subjects. The allocation sequence will be concealed from the researcher (A.A) enrolling and assessing participants in sequentially numbered, opaque, sealed and stapled envelopes with the participant's the name and date of birth are written before the intervention. Allocation concealment seeks to prevent selection bias, protects the assignment sequence until allocation. A Ethical approval will be granted by Jordan University of science and technology research center, and permission will be given at postgraduate dental clinics at Jordan University of science and technology, Irbid, Jordan. We hypothesized that 50% increased in rate of tooth movement in MOP group would produce a clinically significant difference. The sample size was calculated depend on a type I error frequency of 5%. According to the power analysis and assuming a large effect size difference between groups with 50% of acceleration rate of tooth movement, the power analysis yields a total sample size estimate of 44 samples at a conventional alpha-level (p = 0.05) and desired power (1 - β err prob) of 0.90, yielding 22 samples per group (means 22 patients that represent 22 MOP group and 22 Control group). Assuming an overall attrition rate of 15%, initial recruitment should target a total of 55 samples with 18 patients per group. All calculations were performed with the computer application G-Power (Erdfelder et al., 1996)

Interventions

Three Micro-osteoperforation (MOPs) will be performed distal to canine by Mini screw. Before the application of the MOPs, Patient will be asked to wash their mouth twice by chorhexidine for 1 minute.

Sponsors

Jordan University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female * between 16 to 26 years old * Class II Division 1 malocclusion or bimaxillary protrusion * Average Lower facial height and Mandibular plane angle * No systemic disease * Healthy periodontal condition * Non smoker * Probing depth less than 4 mm in all teeth

Exclusion criteria

* Long-term use of any Medication * Poor oral hygiene * Low and high angle cases * Systemic disease * Evidence of bone loss * Active periodontal disease * Smoker * Probing depth more than 4 mm in all teeth Cephalometric analysis of the included subjects was performed at baseline including 1. Sella-Nasion to A Point Angle (SNA): Measure Description: Sella-Nasion-A point (SNA) indicates the horizontal position of the maxilla relative to the cranial base. 2. Sella-Nasion to B Point Angle (SNB): Sella-Nasion-B point (SNB) indicates the horizontal position of the mandible relative to the cranial base. 3. A point to B Point Angle (ANB): A point- Nasion-B point (ANB) indicates the skeletal relationship between the maxilla and mandible. 4. Maxillary mandibular plane angle (MM): The angle formed between the Maxillary Plane and Mandibular Plane. Maxillary Plane is the plane demonstrated by a line through the anterior and posterior nasal spines.A mandibular plane is a plane demonstrated by a line through the gonion and menton. 5. Lower anterior facial height(LAFH) 6. Upper incisor inclination: The angle between the maxillary plane and the axis of the maxillary incisors.

Design outcomes

Primary

MeasureTime frameDescription
3D Digital Model Measurements of Canine Rate of Tooth MovementBaseline to 1st monthThe baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.
Intra Oral Measurements of Canine Rate of Tooth MovementBaseline to 1st monthDirect intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Secondary

MeasureTime frameDescription
Pain Interference /Pain During Eating?within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
Pain Interference /Pain Interrupted Sleepwithin 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
Pain Interference /Swelling of the Surgical Sidewithin 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no swelling and 10 = worst swelling.
Root ResorptionBaseline to 3rd monthIt will be evaluated by taking periapical radiograph for canines before canine retraction and after 3 months period
Patient SatisfactionAfter 7 days of MOP applicationIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = unsatisfied and 10 = most satisfaction.
Menstrual Cyclewithin 3 monthsthe relationship between the rate of tooth movement and Menstrual cycle
Pain Interference /Discomfortwithin 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no discomfort and 10 = worst discomfort.
Pain Intensitywithin 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Countries

Jordan

Participant flow

Recruitment details

Participants recruited from a postgraduate clinic at Jordanian University of Science and Technology, in Irbid city, Jordan between Aug 2015 and Jan 2016.

Participants by arm

ArmCount
All Study Participants
Includes groups randomized to receive MOP intervention on one side while the other side serve as control side.
35
Total35

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1
Overall Studypoor oral hygiene2

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous19.26 years
STANDARD_DEVIATION 2.48
A point to B Point Angle (ANB)5.5 Degree
STANDARD_DEVIATION 2.69
Lower anterior facial height(LAFH)55.67 mm
STANDARD_DEVIATION 1.81
Maxillary mandibular plane angle28.9 Degree
STANDARD_DEVIATION 4.27
Region of Enrollment
Jordan
35 participants
Sella-Nasion to A Point Angle (SNA)81.9 Degree
STANDARD_DEVIATION 4.07
Sella-Nasion to B Point Angle (SNB)76.5 Degree
STANDARD_DEVIATION 3.85
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
10 Participants
Upper incisor inclination119.94 Degree
STANDARD_DEVIATION 7.53

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
0 / 320 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

3D Digital Model Measurements of Canine Rate of Tooth Movement

The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.

Time frame: Baseline to 1st month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion.

ArmMeasureValue (MEAN)Dispersion
MOP Side3D Digital Model Measurements of Canine Rate of Tooth Movement0.65 mmStandard Deviation 0.26
Control Side3D Digital Model Measurements of Canine Rate of Tooth Movement0.67 mmStandard Deviation 0.34
p-value: 0.77t-test, 2 sided
Primary

3D Digital Model Measurements of Canine Rate of Tooth Movement

The baseline 3D digital model was superimposed to 3D digital models of 3rd month to determine the anterioposterior displacement of canines.

Time frame: Baseline to 3rd month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion, and only one impression was lost to be taken by a clinician at two months.

ArmMeasureValue (MEAN)Dispersion
MOP Side3D Digital Model Measurements of Canine Rate of Tooth Movement1.93 mmStandard Deviation 0.74
Control Side3D Digital Model Measurements of Canine Rate of Tooth Movement1.88 mmStandard Deviation 0.67
p-value: 0.76t-test, 2 sided
Primary

3D Digital Model Measurements of Canine Rate of Tooth Movement

The baseline 3D digital model was superimposed to 3D digital models of 2nd month to determine the anterioposterior displacement of canines.

Time frame: Baseline to 2nd month

Population: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. only one impression was lost to be taken by a clinician at two months period.

ArmMeasureValue (MEAN)Dispersion
MOP Side3D Digital Model Measurements of Canine Rate of Tooth Movement1.36 mmStandard Deviation 0.49
Control Side3D Digital Model Measurements of Canine Rate of Tooth Movement1.28 mmStandard Deviation 0.5
p-value: 0.5t-test, 2 sided
Primary

Intra Oral Measurements of Canine Rate of Tooth Movement

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Time frame: Baseline to 3 month

Population: 32 subjects were analyzed who received MOP to either right or left sides.

ArmMeasureValue (MEAN)Dispersion
MOP SideIntra Oral Measurements of Canine Rate of Tooth Movement3.18 mmStandard Deviation 1.03
Control SideIntra Oral Measurements of Canine Rate of Tooth Movement3.26 mmStandard Deviation 0.81
p-value: 0.74t-test, 2 sided
Primary

Intra Oral Measurements of Canine Rate of Tooth Movement

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Time frame: Baseline to 1st month

Population: 32 subjects were analyzed to receive MOP to either right or left sides. Only one patient was lost to follow up at the first month time point.

ArmMeasureValue (MEAN)Dispersion
MOP SideIntra Oral Measurements of Canine Rate of Tooth Movement1.23 mmStandard Deviation 0.45
Control SideIntra Oral Measurements of Canine Rate of Tooth Movement1.17 mmStandard Deviation 0.42
p-value: 0.56t-test, 2 sided
Primary

Intra Oral Measurements of Canine Rate of Tooth Movement

Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.

Time frame: Baseline to 2nd month

Population: 32 subjects were analyzed to receive MOP to either right or left sides.

ArmMeasureValue (MEAN)Dispersion
MOP SideIntra Oral Measurements of Canine Rate of Tooth Movement2.27 mmStandard Deviation 0.72
Control SideIntra Oral Measurements of Canine Rate of Tooth Movement2.24 mmStandard Deviation 0.63
p-value: 0.88t-test, 2 sided
Secondary

Menstrual Cycle

the relationship between the rate of tooth movement and Menstrual cycle

Time frame: within 3 months

Population: Sufficient data were not collected from any participant

Secondary

Pain Intensity

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Time frame: within 7 days after the intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOP SidePain Intensity12 hour2.6 units on a scaleStandard Deviation 2.79
MOP SidePain IntensityDay 30.8 units on a scaleStandard Deviation 1.41
MOP SidePain Intensity1 hour2.4 units on a scaleStandard Deviation 2.15
MOP SidePain IntensityDay 50.4 units on a scaleStandard Deviation 1.1
MOP SidePain IntensityDay 11.2 units on a scaleStandard Deviation 1.95
MOP SidePain IntensityDay 70.2 units on a scaleStandard Deviation 0.71
MOP SidePain IntensityImmediate1.4 units on a scaleStandard Deviation 1.74
Control SidePain IntensityDay 70.3 units on a scaleStandard Deviation 1.28
Control SidePain IntensityImmediate1.0 units on a scaleStandard Deviation 1.99
Control SidePain Intensity1 hour1.5 units on a scaleStandard Deviation 2.23
Control SidePain Intensity12 hour1.6 units on a scaleStandard Deviation 2.35
Control SidePain IntensityDay 10.8 units on a scaleStandard Deviation 1.36
Control SidePain IntensityDay 30.6 units on a scaleStandard Deviation 1.29
Control SidePain IntensityDay 50.3 units on a scaleStandard Deviation 1.18
Comparison: Immediate after interventionp-value: 0.388t-test, 2 sided
Comparison: 1 hour after interventionp-value: 0.092t-test, 2 sided
Comparison: 12 hour after interventionp-value: 0.1t-test, 2 sided
Comparison: Day 1 after interventionp-value: 0.302t-test, 2 sided
Comparison: Day 3 after interventionp-value: 0.582t-test, 2 sided
Comparison: Day 5 after interventionp-value: 0.743t-test, 2 sided
Comparison: Day 7 after interventionp-value: 0.809t-test, 2 sided
Secondary

Pain Interference /Discomfort

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no discomfort and 10 = worst discomfort.

Time frame: within 7 days after the intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOP SidePain Interference /DiscomfortDay 12.10 units on a scaleStandard Deviation 2.52
MOP SidePain Interference /DiscomfortDay 30.77 units on a scaleStandard Deviation 1.36
MOP SidePain Interference /DiscomfortDay 50.23 units on a scaleStandard Deviation 0.56
MOP SidePain Interference /DiscomfortDay 70.06 units on a scaleStandard Deviation 0.25
Control SidePain Interference /DiscomfortDay 70.03 units on a scaleStandard Deviation 0.18
Control SidePain Interference /DiscomfortDay 11.29 units on a scaleStandard Deviation 2.19
Control SidePain Interference /DiscomfortDay 50.10 units on a scaleStandard Deviation 0.4
Control SidePain Interference /DiscomfortDay 30.58 units on a scaleStandard Deviation 1.29
Comparison: Day 1p-value: 0.18t-test, 2 sided
Comparison: Day 3p-value: 0.57t-test, 2 sided
Comparison: Day 5p-value: 0.3t-test, 2 sided
Comparison: Day 7p-value: 0.56t-test, 2 sided
Secondary

Pain Interference /Pain During Eating?

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Time frame: within 7 days after the intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOP SidePain Interference /Pain During Eating?Day 13.10 units on a scaleStandard Deviation 2.61
MOP SidePain Interference /Pain During Eating?Day 31.03 units on a scaleStandard Deviation 1.58
MOP SidePain Interference /Pain During Eating?Day 50.29 units on a scaleStandard Deviation 0.74
MOP SidePain Interference /Pain During Eating?Day 70.13 units on a scaleStandard Deviation 0.56
Control SidePain Interference /Pain During Eating?Day 70.10 units on a scaleStandard Deviation 0.54
Control SidePain Interference /Pain During Eating?Day 12.00 units on a scaleStandard Deviation 2.54
Control SidePain Interference /Pain During Eating?Day 50.19 units on a scaleStandard Deviation 0.6
Control SidePain Interference /Pain During Eating?Day 30.65 units on a scaleStandard Deviation 1.23
Comparison: Day 1p-value: 0.09t-test, 2 sided
Comparison: Day 3p-value: 0.29t-test, 2 sided
Comparison: Day 5p-value: 0.57t-test, 2 sided
Comparison: Day 7p-value: 0.82t-test, 2 sided
Secondary

Pain Interference /Pain Interrupted Sleep

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.

Time frame: within 7 days after the intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOP SidePain Interference /Pain Interrupted SleepDay 10.58 units on a scaleStandard Deviation 1.69
MOP SidePain Interference /Pain Interrupted SleepDay 30.13 units on a scaleStandard Deviation 0.56
MOP SidePain Interference /Pain Interrupted SleepDay 50.06 units on a scaleStandard Deviation 0.36
MOP SidePain Interference /Pain Interrupted SleepDay 70.00 units on a scaleStandard Deviation 0
Control SidePain Interference /Pain Interrupted SleepDay 70.00 units on a scaleStandard Deviation 0
Control SidePain Interference /Pain Interrupted SleepDay 10.19 units on a scaleStandard Deviation 0.91
Control SidePain Interference /Pain Interrupted SleepDay 50.00 units on a scaleStandard Deviation 0
Control SidePain Interference /Pain Interrupted SleepDay 30.03 units on a scaleStandard Deviation 0.18
Comparison: Day 1p-value: 0.27t-test, 2 sided
Comparison: Day 3p-value: 0.37t-test, 2 sided
Comparison: Day 5p-value: 0.33t-test, 2 sided
Comparison: Day 7p-value: >0.05t-test, 2 sided
Secondary

Pain Interference /Swelling of the Surgical Side

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no swelling and 10 = worst swelling.

Time frame: within 7 days after the intervention

ArmMeasureGroupValue (MEAN)Dispersion
MOP SidePain Interference /Swelling of the Surgical SideDay 11.23 units on a scaleStandard Deviation 1.68
MOP SidePain Interference /Swelling of the Surgical SideDay 30.48 units on a scaleStandard Deviation 1.18
MOP SidePain Interference /Swelling of the Surgical SideDay 50.26 units on a scaleStandard Deviation 0.82
MOP SidePain Interference /Swelling of the Surgical SideDay 70.06 units on a scaleStandard Deviation 0.25
Control SidePain Interference /Swelling of the Surgical SideDay 70.00 units on a scaleStandard Deviation 0
Control SidePain Interference /Swelling of the Surgical SideDay 10.41 units on a scaleStandard Deviation 1.38
Control SidePain Interference /Swelling of the Surgical SideDay 50.00 units on a scaleStandard Deviation 0
Control SidePain Interference /Swelling of the Surgical SideDay 30.26 units on a scaleStandard Deviation 1.26
Comparison: Day 1p-value: 0.05t-test, 2 sided
Comparison: Day 3p-value: 0.47t-test, 2 sided
Comparison: Day 5p-value: 0.09t-test, 2 sided
p-value: 0.16t-test, 2 sided
Secondary

Patient Satisfaction

It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = unsatisfied and 10 = most satisfaction.

Time frame: After 7 days of MOP application

ArmMeasureValue (MEAN)Dispersion
MOP SidePatient Satisfaction8.94 units on a scaleStandard Deviation 1.35
p-value: <0.05Descriptive statistics
Secondary

Root Resorption

It will be evaluated by taking periapical radiograph for canines before canine retraction and after 3 months period

Time frame: Baseline to 3rd month

ArmMeasureGroupValue (MEAN)Dispersion
MOP SideRoot ResorptionRoot length at baseline19.96 mmStandard Deviation 2.2
MOP SideRoot ResorptionRoot length at 3 months19.35 mmStandard Deviation 2
Control SideRoot ResorptionRoot length at baseline19.66 mmStandard Deviation 2.5
Control SideRoot ResorptionRoot length at 3 months18.93 mmStandard Deviation 2.6
Comparison: Root length at baseline.p-value: 0.59t-test, 2 sided
Comparison: Root length at 3 monthsp-value: 0.48t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026